Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ToGA study: trastuzumab plus chemotherapy vs chemotherapy in HER2-positive advanced gastric cancer
jRCT2080220186Phase 3
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Dec 2005
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of trastuzumab in gastric adenocarcinoma and gastroesophageal junction adenocarcinoma (2 arms), sponsored by Chugai Pharmaceutical Co., Ltd.
02
Drugs
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on jRCT2080220186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220186.